442 related articles for article (PubMed ID: 25083058)
41. Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome.
Cremon C; Carini G; Wang B; Vasina V; Cogliandro RF; De Giorgio R; Stanghellini V; Grundy D; Tonini M; De Ponti F; Corinaldesi R; Barbara G
Am J Gastroenterol; 2011 Jul; 106(7):1290-8. PubMed ID: 21427712
[TBL] [Abstract][Full Text] [Related]
42. The pathophysiology of irritable bowel syndrome.
Schwetz I; Bradesi S; Mayer EA
Minerva Med; 2004 Oct; 95(5):419-26. PubMed ID: 15467517
[TBL] [Abstract][Full Text] [Related]
43. Sensory neuro-immune interactions differ between irritable bowel syndrome subtypes.
Hughes PA; Harrington AM; Castro J; Liebregts T; Adam B; Grasby DJ; Isaacs NJ; Maldeniya L; Martin CM; Persson J; Andrews JM; Holtmann G; Blackshaw LA; Brierley SM
Gut; 2013 Oct; 62(10):1456-65. PubMed ID: 22767422
[TBL] [Abstract][Full Text] [Related]
44. Serum and colonic mucosal immune markers in irritable bowel syndrome.
Chang L; Adeyemo M; Karagiannides I; Videlock EJ; Bowe C; Shih W; Presson AP; Yuan PQ; Cortina G; Gong H; Singh S; Licudine A; Mayer M; Tache Y; Pothoulakis C; Mayer EA
Am J Gastroenterol; 2012 Feb; 107(2):262-72. PubMed ID: 22158028
[TBL] [Abstract][Full Text] [Related]
45. The shifting interface between IBS and IBD.
Spiller R; Lam C
Curr Opin Pharmacol; 2011 Dec; 11(6):586-92. PubMed ID: 22000604
[TBL] [Abstract][Full Text] [Related]
46. Potential neuro-immune therapeutic targets in irritable bowel syndrome.
Casado-Bedmar M; Keita ÅV
Therap Adv Gastroenterol; 2020; 13():1756284820910630. PubMed ID: 32313554
[TBL] [Abstract][Full Text] [Related]
47. Irritable bowel syndrome: the role of gut neuroendocrine peptides.
El-Salhy M; Seim I; Chopin L; Gundersen D; Hatlebakk JG; Hausken T
Front Biosci (Elite Ed); 2012 Jun; 4(8):2783-800. PubMed ID: 22652678
[TBL] [Abstract][Full Text] [Related]
48. Indication of immune activation in patients with perceived food hypersensitivity.
Lied GA
Dig Dis Sci; 2014 Feb; 59(2):259-66. PubMed ID: 24185686
[TBL] [Abstract][Full Text] [Related]
49. [Psychosocial factors and visceral hypersensitivity in irritable bowel syndrome].
Lee OY
Korean J Gastroenterol; 2006 Feb; 47(2):111-9. PubMed ID: 16498276
[TBL] [Abstract][Full Text] [Related]
50. Associations among gut permeability, inflammatory markers, and symptoms in patients with irritable bowel syndrome.
Shulman RJ; Jarrett ME; Cain KC; Broussard EK; Heitkemper MM
J Gastroenterol; 2014 Nov; 49(11):1467-76. PubMed ID: 24435814
[TBL] [Abstract][Full Text] [Related]
51. The putative role of the intestinal microbiota in the irritable bowel syndrome.
Collins SM; Denou E; Verdu EF; Bercik P
Dig Liver Dis; 2009 Dec; 41(12):850-3. PubMed ID: 19740713
[TBL] [Abstract][Full Text] [Related]
52. Functional findings in irritable bowel syndrome.
Posserud I; Ersryd A; Simrén M
World J Gastroenterol; 2006 May; 12(18):2830-8. PubMed ID: 16718806
[TBL] [Abstract][Full Text] [Related]
53. Peripheral Corticotropin-Releasing Factor Triggers Jejunal Mast Cell Activation and Abdominal Pain in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.
Guilarte M; Vicario M; Martínez C; de Torres I; Lobo B; Pigrau M; González-Castro A; Rodiño-Janeiro BK; Salvo-Romero E; Fortea M; Pardo-Camacho C; Antolín M; Saperas E; Azpiroz F; Santos J; Alonso-Cotoner C
Am J Gastroenterol; 2020 Dec; 115(12):2047-2059. PubMed ID: 32740086
[TBL] [Abstract][Full Text] [Related]
54. [Irritable bowel syndrome with extraintestinal manifestations from a position of neuroendocrine pathology].
Osadchuk MA; Burdina VO
Eksp Klin Gastroenterol; 2015; (2):29-34. PubMed ID: 25993870
[TBL] [Abstract][Full Text] [Related]
55. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options.
Konturek PC; Brzozowski T; Konturek SJ
J Physiol Pharmacol; 2011 Dec; 62(6):591-9. PubMed ID: 22314561
[TBL] [Abstract][Full Text] [Related]
56. Immune derived opioidergic inhibition of viscerosensory afferents is decreased in Irritable Bowel Syndrome patients.
Hughes PA; Moretta M; Lim A; Grasby DJ; Bird D; Brierley SM; Liebregts T; Adam B; Blackshaw LA; Holtmann G; Bampton P; Hoffmann P; Andrews JM; Zola H; Krumbiegel D
Brain Behav Immun; 2014 Nov; 42():191-203. PubMed ID: 25063707
[TBL] [Abstract][Full Text] [Related]
57. Crosstalk between interleukin-6 and corticotropin-releasing factor modulate submucosal plexus activity and colonic secretion.
O'Malley D; Cryan JF; Dinan TG
Brain Behav Immun; 2013 May; 30():115-24. PubMed ID: 23369733
[TBL] [Abstract][Full Text] [Related]
58. Irritable bowel syndrome: current review on pathophysiology and diagnotic aspects.
Abdullah M
Acta Med Indones; 2008 Oct; 40(4):218-25. PubMed ID: 19151451
[TBL] [Abstract][Full Text] [Related]
59. Probiotics and irritable bowel syndrome.
Dai C; Zheng CQ; Jiang M; Ma XY; Jiang LJ
World J Gastroenterol; 2013 Sep; 19(36):5973-80. PubMed ID: 24106397
[TBL] [Abstract][Full Text] [Related]
60. Histopathological alterations in irritable bowel syndrome.
Kirsch R; Riddell RH
Mod Pathol; 2006 Dec; 19(12):1638-45. PubMed ID: 17013373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
